Horm Metab Res 2002; 34(11/12): 691-697
DOI: 10.1055/s-2002-38251
Original Clinical
© Georg Thieme Verlag Stuttgart · New York

Divergent Effects of Leptin in Mice Susceptible or Resistant to Obesity

N.  Takahashi 1 , H.  R.  Patel 1 , Y.  Qi 1 , J.  Dushay 2 , R.  S.  Ahima 1
  • 1 University of Pennsylvania School of Medicine, Division of Endocrinology, Diabetes and Metabolism, Philadelphia, Pennsylvania, USA
  • 2 Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
Further Information

Publication History

Received 10 October 2002

Accepted after revision 28 November 2002

Publication Date:
27 March 2003 (online)

Abstract

Consumption of a high-fat diet decreases hypothalamic neuropeptide Y (NPY) and increases proopiomelanocortin (POMC) and brown adipose uncoupling protein (UCP)-1 mRNA in obesity-resistant SWR/J but not obesity-prone C57Bl/6J mice. Although leptin was elevated in both strains in response to a high-fat diet, its role in the development of diet-induced obesity has remained unclear since insulin and other factors that affect similar tissue targets are altered. Thus, we administered recombinant leptin by subcutaneous infusion to chow-fed mice to mimic the changes in plasma leptin across its broad physiologic range. We observed strain differences in responsiveness to reduced and elevated leptin levels. A reduction in leptin during fasting evoked a greater response in C57Bl/6J mice by decreasing energy expenditure and thyroxin, increasing corticosterone and stimulating food intake and weight gain during refeeding. However, C57Bl/6J mice were less responsive to an increase in leptin in the fed state. Conversely, the leptin-mediated response to fasting was blunted in SWR/J mice, whereas an increase in leptin profoundly reduced food intake and body weight in SWR/J mice fed ad libitum. Sensitivity to fasting in C57Bl/6J mice was associated with higher hypothalamic NPY mRNA and reduced POMC and UCP-1 mRNA expression, while the robust response to high leptin levels in SWR/J mice was associated with suppression of NPY mRNA. These results indicate that differences in leptin responsiveness between strains might occur centrally or peripherally, leading to alteration in the patterns of food intake, thermogenesis and energy storage.

References

  • 1 Friedman J M, Halaas J L. Leptin and the regulation of body weight in mammals.  Nature. 1998;  395 763-770
  • 2 Flier J S. Clinical review 94: What’s in a name? In search of leptin’s physiologic role.  J Clin Endocrinol Metab. 1998;  83 1407-1413
  • 3 Barsh G S, Farooqi I S, O’Rahilly S. Genetics of body-weight regulation.  Nature. 2000;  404 644-651
  • 4 Surwit R S, Petro A E, Parekh P, Collins S. Low plasma leptin in response to dietary fat in diabetes- and obesity-prone mice.  Diabetes. 1997;  46 1516-1520
  • 5 Bergen H T, Mizuno T, Taylor J, Mobbs C V. Resistance to diet-induced obesity is associated with increased proopiomelanocortin mRNA and decreased neuropeptide Y mRNA in the hypothalamus.  Brain Res. 1999;  851 198-203
  • 6 van Heek M, Compton D S, France C F, Tedesco R P, Fawzi A B, Graziano M P, Sybertz E J, Strader C D, Davis H R. Diet-induced obese mice develop peripheral, but not central resistance to leptin.  J Clin Invest. 1997;  99 385-390
  • 7 Farooqi I S, Keogh J M, Kamath S, Jones S, Gibson W T, Trussell R, Jebb S A, Lip G Y, O’Rahilly S. Partial leptin deficiency and human adiposity.  Nature. 2001;  414 34-35
  • 8 Watson P M, Commins S P, Beiler R J, Hatcher H C, Gettys T W. Differential regulation of leptin expression and function in A/J vs. C57BL/6J mice during diet-induced obesity.  Am J Physiol Endocrinol Metab. 2000;  279 E356-E365
  • 9 West D B, Waguespack J, McCollister S. Dietary obesity in the mouse: interaction of strain with diet composition.  Am J Physiol. 1995;  268 R658-R665
  • 10 West D B, Waguespack J, York B, Goudey-Lefevre J, Price R A. Genetics of dietary obesity in AKR/J x SWR/J mice: segregation of the trait and identification of a linked locus on chromosome 4.  Mamm Genome. 1994;  5 546-552
  • 11 Ziotopoulou M, Mantzoros C S, Hileman S M, Flier J S. Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice.  Am J Physiol Endocrinol Metab. 2000;  279 E838-E845
  • 12 Ahima R S, Patel H R, Takahashi N, Qi Y, Hileman S M, Zasloff M A. Appetite suppression and weight reduction by a centrally active aminosterol.  Diabetes. 2002;  51 2099-2104
  • 13 Asnicar M A, Koster A, Heiman M L, Tinsley F, Smith D P, Galbreath E, Fox N, Ma Y L, Blum W F, Hsiung H M. Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate.  Endocrinology. 2002;  143 3994-4006
  • 14 Chen A S, Marsh D J, Trumbauer M E, Frazier E G, Guan X M, Yu H, Rosenblum C I, Vongs A, Feng Y, Cao L, Metzger J M, Strack A M, Camacho R E, Mellin T N, Nunes C N, Min W, Fisher J, Gopal-Truter S, MacIntyre D E, Chen H Y, van der Ploeg L H. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass.  Nat Genet. 2000;  26 97-102
  • 15 Ahima R S, Kelly J, Elmquist J K, Flier J S. Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia.  Endocrinology. 1999;  140 4923-4931
  • 16 Ahima R S, Hileman S M. Postnatal regulation of hypothalamic neuropeptide expression by leptin: implications for energy balance and body weight regulation.  Regul Pept. 2000;  92 1-7
  • 17 Ziotopoulou M, Erani D M, Hileman S M, Bjorbaek C, Mantzoros C S. Unlike leptin, ciliary neurotrophic factor does not reverse the starvation-induced changes of serum corticosterone and hypothalamic neuropeptide levels but induces expression of hypothalamic inhibitors of leptin signaling.  Diabetes. 2000;  49 1890-1896
  • 18 Rizk N M, Stammsen D, Preibisch G, Eckel J. Leptin and tumor necrosis factor-alpha induce the tyrosine phosphorylation of signal transducer and activator of transcription proteins in the hypothalamus of normal rats in vivo.  Endocrinology. 2001;  142 3027-3032
  • 19 Niswender K D, Morton G J, Stearns W H, Rhodes C J, Myers M G, Schwartz M W. Intracellular signalling. Key enzyme in leptin-induced anorexia.  Nature. 2001;  413 794-795
  • 20 Ahima R S, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier J S. Role of leptin in the neuroendocrine response to fasting.  Nature. 1996;  382 250-252
  • 21 Legradi G, Emerson C H, Ahima R S, Flier J S, Lechan R M. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus.  Endocrinology. 1997;  138 2569-2576
  • 22 Chen Y, Heiman M L. Chronic leptin administration promotes lipid utilization until fat mass is greatly reduced and preserves lean mass of normal female rats.  Regul Pept. 2000;  92 113-119
  • 23 Halaas J L, Boozer C, Blair-West J, Fidahusein N, Denton D A, Friedman J M. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice.  Proc Natl Acad Sci USA. 1997;  94 8878-8883
  • 24 Dhillon H, Kalra S P, Prima V, Zolotukhin S, Scarpace P J, Moldawer L L, Muzyczka N, Kalra P S. Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study.  Regul Pept. 2001;  99 69-77
  • 25 Surwit R S, Wang S, Petro A E, Sanchis D, Raimbault S, Ricquier D, Collins S. Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice.  Proc Natl Acad Sci USA. 1998;  95 4061-4065
  • 26 Neel J V. Diabetes mellitus: A “thrifty” genotype rendered detrimental by “progress”.  Am J Hum Genet. 1962;  14 353-362
  • 27 Banks W A, Clever C M, Farrell C L. Partial saturation and regional variation in the blood-to-brain transport of leptin in normal weight mice.  Am J Physiol Endocrinol Metab. 2000;  278 E1158-1165
  • 28 Ahima R S, Flier J S. Leptin.  Annu Rev Physiol. 2000;  62 413-437

R. S. Ahima, M.D., Ph.D.

University of Pennsylvania School of Medicine · Division of Endocrinology, Diabetes and Metabolism

415 Curie Blvd. · 764 Clinical Research Building · Philadelphia, PA 19104 · USA